Xuejia Kang - Concepedia

Author

Xuejia Kang

Shanghai Institute of Materia Medica ORCID

Also Known As

Kang, X.; Wang, Q.; Wu, S.; Wang, C.; Annaji, M.; Huang, C.H.; Shen, J.; Chen, P.; Babu, R.J., Xiaorui Kang, Xue-jia Kang, Xuejia Kang

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Shanghai Institute of Materia Medica Chinese Academy of Sciences Guangzhou University of Chinese Medicine Auburn University Nanchang University

About

Xuejia Kang is an author at Shanghai Institute of Materia Medica specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	354
2	Biomolecular Engineering	3	3	174
3	Engineering	2	2	178
4	Health Sciences	2	2	63
5	Biomedical Engineering	1	1	70

Xuejia Kang

Publications

Citations

H-Index

Page 1

	Year	Citations
Dual-targeting biomimetic delivery for anti-glioma activity<i>via</i>remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy Pengfei Zhao, Yonghui Wang, Xuejia Kang, Chemical Science	2018	243
Remodeling tumor immune microenvironment (TIME) for glioma therapy using multi-targeting liposomal codelivery Zening Zheng, Jiaxin Zhang, Jizong Jiang, Journal for ImmunoTherapy of Cancer	2020	132
Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy Xuejia Kang, Huiyuan Wang, Huige Peng, Acta Pharmacologica Sinica NanomedicineMedicinal ChemistryEngineeringPolymer-drug ConjugateMedicine	2017	108
BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR<sup>T790M</sup> mutation Weimin Yin, Yuge Zhao, Xuejia Kang, Theranostics	2020	93
Remodeling Tumor‐Associated Macrophages and Neovascularization Overcomes EGFR<sup>T790M</sup>‐Associated Drug Resistance by PD‐L1 Nanobody‐Mediated Codelivery Weimin Yin, Xiaolu Yu, Xuejia Kang, Small	2018	78
Liposomal Codelivery of Doxorubicin and Andrographolide Inhibits Breast Cancer Growth and Metastasis Xuejia Kang, Zening Zheng, Zehua Liu, Molecular Pharmaceutics Breast OncologyEngineeringBiomedical EngineeringCancer BiologyTumor Biology	2018	70
Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide Xiaopeng Mo, Zening Zheng, Yang He, Journal of Controlled Release OxysterolLactoferrin-mediated Biomimetic CodeliveryMedicineNeuroprotectionAnti-cancer Agent	2018	68
Nano-Structural Effects on Gene Transfection: Large, Botryoid-Shaped Nanoparticles Enhance DNA Delivery via Macropinocytosis and Effective Dissociation Wenyuan Zhang, Xuejia Kang, Bo Yuan, Theranostics	2019	37
A mannosylated PEI–CPP hybrid for TRAIL gene targeting delivery for colorectal cancer therapy Zhenzhen Pan, Xuejia Kang, Zeng Yuan-er, Polymer Chemistry Tumor BiologyDrug TargetingColorectal Cancer TherapyGastrointestinal OncologyMedicine	2017	34
Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein Xuejia Kang, Junwei Wang, Chung-Hui Huang, Nanomedicine Nanotechnology Biology and Medicine Cancer TherapyNanomedicineNanotherapeuticsHealth SciencesPolymer-drug Conjugate	2022	32

Page 1